Authors: Chang, IS Gander, M Jefferson, B Judd, SJ

Citation: Is. Chang et al., Low-cost membranes for use in a submerged MBR, PROCESS SAF, 79(B3), 2001, pp. 183-188

Authors: Gander, M Jefferson, B Judd, S

Citation: M. Gander et al., Aerobic MBRs for domestic wastewater treatment: a review with cost considerations, SEP PURIF T, 18(2), 2000, pp. 119-130

Authors: Gander, M Nataf, F

Citation: M. Gander et F. Nataf, AILU for Helmholtz problems: a new preconditioner based on an analytic factorization, CR AC S I, 331(3), 2000, pp. 261-266

Authors: Hartley, JM Spanswick, VJ Gander, M Giacomini, G Whelan, J Souhami, RL Hartley, JA

Citation: Jm. Hartley et al., Measurement of DNA cross-linking in patients on ifosfamide therapy using the single cell gel electrophoresis (comet) assay, CLIN CANC R, 5(3), 1999, pp. 507-512

Authors: Gander, M Leyvraz, S Decosterd, L Bonfanti, M Marzolini, C Shen, F Lienard, D Perey, L Colella, G Biollaz, J Lejeune, F Yarosh, D Belanich, M D'Incalci, M

Citation: M. Gander et al., Sequential administration of temozolomide and fotemustine: Depletion of O-6-alkyl guanine-DNA transferase in blood lymphocytes and in tumours, ANN ONCOL, 10(7), 1999, pp. 831-838

Authors: Marzolini, C Decosterd, LA Shen, F Gander, M Leyvraz, S Bauer, J Buclin, T Biollaz, J Lejeune, F

Citation: C. Marzolini et al., Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration (vol 42, pg 433, 1998), CANC CHEMOT, 43(5), 1999, pp. 439-440